New On Robinhood

CureVac

$101.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.02%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell CureVac and other stocks, options, and ETFs commission-free!

About CVAC

CureVac N.V. Ordinary Shares, also called CureVac, is a clinical-stage biopharmaceutical company developing transformative medicines. It offers RNA optimization that encode functional proteins that replace defective or missing proteins using the cell's intrinsic translation machinery. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany. The listed name for CVAC is CureVac N.V. Ordinary Shares.

CEO
Franz-Werner Haas
Employees
454
Headquarters
Tubingen, Baden Wuerttemberg
Founded
2000
Market Cap
17.49B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
502.47K
High Today
$103.13
Low Today
$98.83
Open Price
$101.94
Volume
281.43K
52 Week High
$151.80
52 Week Low
$36.15

Collections

CVAC Earnings

-$65.03
-$43.35
-$21.68
$0.00
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 1, Pre-Market

You May Also Like

KMED
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure